Shares of the Vadodara-based pharmaceutical firm rose as much as 5.4 percent to Rs 570.
Alembic Pharmaceuticals has received approval from the U.S. drug regulator for Acyclovir, which is used in the treatment of genital herpes, it said in a notification to the stock exchanges.
